South Africa’s richest man Johann Rupert’s Richemont hits $6.1 billion in Q3 sales
Rupert’s wealth skyrockets to $12 billion as Richemont’s sales surpass expectations.
Rupert’s wealth skyrockets to $12 billion as Richemont’s sales surpass expectations.
The bank is eyeing substantial funding of up to $100 million in a Series-D round.
The market value of the Saltzman family’s joint stake in Dis-Chem Pharmacies has declined from $487.7 million on Jan. 1 to $465.61 million.
The recent increase in his wealth figures, driven by a sharp rise in Richemont’s share price, trimmed his year-to-date losses to $442 million.
Motsepe, the influential owner with a substantial stake in TymeBank, emphasized the bank’s appeal to a more affluent consumer market.
India’s economy is growing nearly five times faster than South Africa’s.
Glasenberg’s wealth is derived from his 9.81-percent stake in Glencore, a Swiss multinational commodity trading and mining company.
Despite a 10-percent plunge in the market value of Motsepe’s 40-percent stake in ARM, the surge in his net worth is linked to the revaluation of private investments.
The key factor behind the plunge in Johann Rupert’s fortune is the recent decline in the market value of his 10.18-percent stake in Richemont.
Naspers South Africa CEO Phuthi Mahanyele-Dabengwa affirmed the group’s commitment to fortify its businesses in anticipation of Amazon’s impending entry.
The court decision impacts the ARM-Glencore joint venture’s financial standing.
Since its inception, Le Roux has played a pivotal role in shaping the landscape of the financial services industry throughout Africa.
Navigating headwinds: Bekker’s Prosus N.V. stake takes a hit amid industry disruptions.
The surge in Rupert’s fortune not only cements his position as one of Africa’s richest billionaires but also propels him to the top of South Africa’s wealth hierarchy.
The decline in his net worth is closely tied to the sustained downturn in the market value of his 40.37-percent stake in African Rainbow Minerals (ARM).
Lynette and Ivan Saltzman own a beneficial 35.12-percent stake in the Gauteng-based Dis-Chem Pharmacies.